Pulmonology

Developmental Disabilities Linked to Greater Pediatric Asthma Risk

July 02, 2020

Article

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

Dexamethasone Recommended for Mechanically Ventilated COVID-19 Patients

July 01, 2020

Article

Dexamethasone should also be used for up to 10 days in patients with COVID-19 who require supplemental oxygen but are not mechanically ventilated.

Expanding the ETHOS Data

June 29, 2020

Article

Where do investigators go next with the 8000-plus COPD patient research?

Topline Sotatercept Results Positive Treating Pulmonary Arterial Hypertension

June 26, 2020

Article

Both dosage groups of the study drug achieved at least a 50-meter increase from baseline to week 24 on the six-minute walk distance test.

Phase 3 Data Points to Treprostinil as a Treatment for Pulmonary Hypertension

June 25, 2020

Article

Treatment with treprostinil of up to 12 breaths per session four-times per data was well-tolerated, with a safety profile consistent with previous studies.

Individualizing COPD Care

June 25, 2020

Article

In an era of triple therapy combinations, what might a tailored approach look like?

Budesonide Plus LAMA/LABA Significantly Reduces Annual COPD Exacerbation

June 24, 2020

Article

New findings from the 8000-plus patient ETHOS trial shows triple inhaler therapy siginificantly betters patient mortality and symptoms over 52 weeks versus dual therapy.

FDA Approves Pre-Filled Dupilumab Pen

June 19, 2020

Article

The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.

Dexamethasone Demonstrates Strong Results for COVID-19

June 19, 2020

Article

The therapy reduces death by 35% in patients with respiratory complications.

Pulmonary Fibrosis and COVID-19 Risk

June 12, 2020

Article

What risks of severity do patients face with viral infection?

x